Palladyne AI is a former robotics de-SPAC that now sells itself as an embodied-autonomy software company while collecting almost all of its cash from recently purchased defense manufacturing and engineering shops. The second-quarter print is the first clean look at that hybrid after a full half-year of ownership. Revenue reached nearly $6 million, which is the figure the market celebrated. The more honest reading is that the namesake software still contributes no licensed product sales, so the multiple is hanging on a hardware-and-services chassis that did not exist a year earlier.
The chassis is not imaginary. Backlog rose to $25 million after a strong award quarter. New bookings added $13 million of committed work, even after the company recognized a record sales print. The Israel Aerospace Industries pact grants exclusive United States rights to the HARPY family of loitering munitions with no cash paid up front, and field work at Ivy Mass put SwarmOS and the Gremlin-X mini bomber in front of the Fourth Infantry Division. Those are real events. They are also still mostly development, trial, and component orders rather than a production franchise. Gross margin sat near twenty-nine percent because the new plants are running below capacity, and operating cash use in the quarter ran above the company's own quarterly average.
Full-year revenue guidance of $24 million to $27 million was left unchanged. That range implies a sharp second-half step-up from a first-half base just above $9 million. Cash and marketable securities ended the quarter at $44 million, roughly unchanged only because the at-the-market program kept selling stock. The investment question is whether backlog, the IAI license, and soldier-facing trials convert into production programs fast enough to shrink the cash hole, or whether the equity remains a software-priced claim on a still-unlicensed autonomy stack.